Financings in Brief: Trinity Biotech
This article was originally published in The Gray Sheet
Executive Summary
Trinity Biotech: Raises $3.1 mil. in private placement of about 2 mil. restricted "A" ordinary shares with European institutional investors. The Dublin, Ireland manufacturer of rapid tests for pregnancy and infectious diseases plans to use part of the proceeds "to gear up for the launch of Trinity's Uni-Gold one-step HIV test in the first quarter of 1996," the firm states...